Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPIP: Remifentanil vs Fentanyl for Neonatal Sedation
NCT00419601Phase 3Completed
- Sponsor
- University of Cologne
- Start
- Nov 2006
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of remifentanil in pain and agitation (2 arms), sponsored by University of Cologne. Primary endpoint: Duration of the artificial ventilation after discontinuation of the opioid infusion at 48 hours. Started Nov 2006; status: completed.
02
Drugs
remifentanil
03
Conditions
painagitation
Beyond the preview
Go deeper on NCT00419601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419601.